Cargando…
Synthetic low-density lipoprotein (sLDL) selectively delivers paclitaxel to tumor with low systemic toxicity
Low density lipoprotein (LDL), which is a principal carrier for the delivery of cholesterol, has been used as a great candidate for the delivery of drugs to tumor based on the great requirements for cholesterol of many cancer cells. Mimicking the structure and composition of LDL, we designed a synth...
Autores principales: | Su, Hai-Tao, Li, Xin, Liang, De-Sheng, Qi, Xian-Rong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5239495/ https://www.ncbi.nlm.nih.gov/pubmed/27409176 http://dx.doi.org/10.18632/oncotarget.10493 |
Ejemplares similares
-
Mathematical Model for Low Density Lipoprotein (LDL) Endocytosis by Hepatocytes
por: Wattis, J. A. D., et al.
Publicado: (2008) -
Low-Density Lipoprotein (LDL)-Antioxidant Biflavonoids from Garcinia madruno
por: Osorio, Edison, et al.
Publicado: (2013) -
Influence of Honey on the Suppression of Human Low Density Lipoprotein (LDL) Peroxidation (In vitro)
por: Hegazi, Ahmed G., et al.
Publicado: (2009) -
Bempedoic Acid: An Emerging Therapy for Uncontrolled Low-Density Lipoprotein (LDL) Cholesterol
por: Pradhan, Akshyaya, et al.
Publicado: (2023) -
Concentration of low-density lipoproteins (LDL) is significantly reduced after nilotinib discontinuation
por: Roa-Chamorro, Ricardo, et al.
Publicado: (2023)